Nada N. Al-Shawi
Nada N. Al-Shawi publishes mostly in Pathology and Forensic Medicine, Pharmacology and Organic Chemistry, on topics such as Drug-Induced Hepatotoxicity and Protection, Chemotherapy-induced organ toxicity mitigation and Chemotherapy-induced cardiotoxicity and mitigation.
- World rank
- #7,560,062 of 7,710,434 ranked researchers
- Rank in Iraq
- #9,031 of 9,225
- Works
- 70
- Citations
- 268
- Citations per work
- 3.8
What does Nada N. Al-Shawi research?
Nada N. Al-Shawi's work is mostly in Medicine (22%), Pharmacology, Toxicology and Pharmaceutics (9%), Chemistry (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3955.1%
- Health Sciences1521.7%
- Medicine1521.7%
- Life Sciences1115.3%
- Physical Sciences67.9%
- Chemistry67.9%
- 1Pathology and Forensic Medicine10% of their works
- 2Pharmacology9% of their works
- 3Organic Chemistry8% of their works
- 4Pulmonary and Respiratory Medicine6% of their works
- 5Molecular Biology6% of their works
- 6Pharmacology5% of their works
Research topics
- Drug-Induced Hepatotoxicity and Protection
- Chemotherapy-induced organ toxicity mitigation
- Chemotherapy-induced cardiotoxicity and mitigation
- Silymarin and Mushroom Poisoning
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Antibiotics Pharmacokinetics and Efficacy
- Nigella sativa pharmacological applications
Which keywords describe Nada N. Al-Shawi's research?
The keywords of their largest research topics: Oxidative Stress, Antioxidants, Mitochondrial Dysfunction, Chemotherapy, Drug-Induced Liver Injury, Hepatotoxicity, Cisplatin and Nephrotoxicity.
- Nigella sativa
- Synthesis
- Heterocyclic Compounds
- Antibiotic Pharmacokinetics
- Liver Diseases
- Anthracyclines
- Nephrotoxicity
- Hepatotoxicity
- Chemotherapy
- Antioxidants
- Oxidative Stress
- Mitochondrial Dysfunction
- Drug-Induced Liver Injury
- Cisplatin
- Antioxidant
- Doxorubicin
- Silymarin
- Critically Ill Patients
- Medicinal Chemistry
- Triazines
- Thymoquinone
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Oxidative Stress333 topics
- Antioxidants252 topics
- Mitochondrial Dysfunction252 topics
- Chemotherapy202 topics
- Drug-Induced Liver Injury131 topic
- Hepatotoxicity131 topic
- Cisplatin121 topic
- Nephrotoxicity121 topic
- Antioxidant112 topics
- Anthracyclines81 topic
- Doxorubicin81 topic
- Liver Diseases71 topic
- Silymarin71 topic
- Antibiotic Pharmacokinetics51 topic
- Critically Ill Patients51 topic
- Heterocyclic Compounds51 topic
- Medicinal Chemistry51 topic
- Synthesis51 topic
- Triazines51 topic
- Nigella sativa41 topic
- Thymoquinone41 topic
Where does Nada N. Al-Shawi work?
Nada N. Al-Shawi's main affiliation in the publication record is University of Baghdad, Iraq.
How many publications and citations does Nada N. Al-Shawi have?
OpenAlex counts 70 works and 268 citations for Nada N. Al-Shawi, an h-index of 8, ranking #7,560,062 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nada N. Al-Shawi. Posts are plain text and can be reported.